Pulmonary hypertension is defined as a mean arterial pressure (MAP) of less than 25 mmHg. With an emphasis on their relevance to congenital heart disease, we investigate the pathogenesis, diagnosis, and treatment of the disease. Pulmonary hypertension is a fairly common complication of congenital heart disease, with an adult prevalence of 5 to 10%. The acknowledged multifactorial cause includes the size and type of the heart abnormality, as well as hereditary and environmental factors. More complex diseases are becoming more widely recognized in place of the pure Eisenmenger complex. A variety of tests, including echocardiography, exercise testing, cardiac catheterization, MRI, and CT scanning, can be used to identify increased pulmonary vascular resistance caused by remodelling of the pulmonary vascular bed. In management, disease-treating medications are utilized, and their efficacy is increasing.
HTML PDFShare this article
Journal of Hypertension: Open Access received 614 citations as per Google Scholar report
